A Case of Neuropsychiatric Systemic Lupus Erythematosus as A Sequela of Kikuchi’s Disease
Abstract
Keywords
DOI: http://dx.doi.org/10.19166/med.v10i2.7024
Full Text:
PDFReferences
1. Bosch X, Guilabert A. Kikuchi-Fujimoto disease. Orphanet J Rare Dis. 2006;3:3–5
2. Humphreys S, Oikonomou KG, Ward N, Aye M. Kikuchi Disease : The Great Masquerador - A Case Report and Review of the Literature. Med Case Rep. 2018; 62:1–4. http://dx.doi.org/10.21767/2471-8041.100097
3. Rahman MSU, Muktadir G, Ahmed SAM. Case Report Kikuchi’s Disease : A Case Report. Faridpur Med Coll J. 2013;8:96–8. https://doi.org/10.3329/fmcj.v8i2.20395
4. Bosch X, Guilabert A, Miquel R, Campo E. Enigmatic Kikuchi-Fujimoto Disease A Comprehensive Review. Am J Clin Pathol. 2004;122:141–52. https://doi.org/10.1309/yf08-1l4t-kywv-yvpq
5. Soedibyo S. Kikuchi-Fujimoto Disease. Med J Indones. 2005;14:107–13. https://doi.org/10.13181/mji.v14i2.178
6. Deaver D, Horna P, Cualing H, Sokol L. Pathogenesis , Diagnosis , and Management of Kikuchi – Fujimoto Disease. Cancer Control. 2014;313–21. https://doi.org/10.1177/107327481402100407
7. Pepe F, Disma S, Teodoro C, Pepe P, Magro G. Kikuchi-Fujimoto disease: A clinicopathologic update. Pathologica. 2015;107:120–9.
8. Baenas DF, Diehl FA, Salinas MJH, Riva V, Diller A, Lemos PA. Kikuchi – Fujimoto disease and systemic lupus erythematosus. Int Med Case Rep J. 2016;9:163–7. https://doi.org/10.2147%2FIMCRJ.S106396
9. Vithoosan S, Karunarathna T, Shanjeeban P, Piranavan P, Matthias T, Gamlaksha D, et al. Kikuchi-Fujimoto disease associated with systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: A case report. J Med Case Rep. 2019;13:1–7. https://doi.org/10.1186%2Fs13256-019-2100-1
10. Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya JM. Introducing polyautoimmunity: Secondary autoimmune diseases no longer exist. Autoimmune Dis. 2012;1. https://doi.org/10.1155%2F2012%2F254319
11. Perry AM, Choi SM. Kikuchi-Fujimoto Disease: A Review. Arch Pathol Lab Med. 2018;142: 1341-6. https://doi.org/10.5858/arpa.2018-0219-ra
12. Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol [Internet]. 2012;24:651–7. Available from: http://dx.doi.org/10.1016/j.coi.2012.10.004
13. Haddad J, Shammaa D, Abbas F, Mahfouz RAR. First report on HLA-DPA1 gene allelic distribution in the general Lebanese population. Meta Gene [Internet]. 2016;8:11–3. Available from: http://dx.doi.org/10.1016/j.mgene.2016.01.004
14. Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, et al. Human leukocyte antigens and systemic lupus erythematosus: A protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03. PLoS One. 2014;9:1–7. https://doi.org/10.1371%2Fjournal.pone.0087792
15. Padhan P, Tripathy KP, Sahoo SR, Maikup D, Mahapatra N. Kikuchi – Fujimoto Disease Presenting as Pyrexia of Unknown Origin. Indian J Rheumatol 2018;13:56-9. http://dx.doi.org/10.4103/injr.injr_101_17
16. López-villegas VJ, Medina-morales DA, Alzate-piedrahita JA, Aguirre AM, Rivera LMS. Kikuchi-Fujimoto disease in a patient with systemic lupus erythematosus and generalized lymphadenopathy. Rev Colomb Reumatol. 2018; 25: 216-20.
17. Neto NSR, Bonfiglioli KR, Milanez FM, Macêdo PA, Levy-Neto M. Lymphadenopathy and systemic lupus erythematosus. Bras J Rheumatol. 2010;50:96-101.
18. Dalton J, Shaw R, Democratis J. Case Report Kikuchi-Fujimoto disease. Lancet [Internet]. 2014;383:1098. Available from: http://dx.doi.org/10.1016/S0140-6736(14)60262-2
19. Santana A, Lessa B, Galrão L, Lima I, Santiago M. Kikuchi-Fujimoto’s disease associated with systemic lupus erythematosus : case report and review of the literature. Clin Rheumatol. 2005;24:60-3. https://doi.org/10.1007/s10067-004-0923-6
20. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism / American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology. 2019;0:1–13. https://doi.org/10.1136/annrheumdis-2018-214819
21. Bichile LS, Chewoolkar VC. Lupus Flare : How to Diagnose and Treat. Med Updat 2011;281–6. https://doi.org/10.31138%2Fmjr.28.1.4
22. Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs. 2016;76:459–83. https://doi.org/10.1007/s40265-015-0534-3
23. Pradhan V, Patwardhan M. Neuropsychiatric manifestations and associated autoantibodies. Rheumatol Int. 2015;541–5. https://doi.org/10.1007/s00296-014-3114-z
24. Zhang Y, Han H, Chu L. Neuropsychiatric lupus erythematosus: Future directions and challenges; a systematic review and survey. Clinics. 2020;75:1–7. https://doi.org/10.6061%2Fclinics%2F2020%2Fe1515
25. Jung JY, Yoon D, Choi Y, Kim HA, Suh CH. Associated clinical factors for serious infections in patients with systemic lupus erythematosus. Sci Rep [Internet]. 2019;9:1–8. https://doi.org/10.1038/s41598-019-46039-5
26. Jung JY, Suh CH. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med. 2019;9:9704. https://doi.org/10.3904/kjim.2016.234
27. Garcia-Cavazos R, Brey R. Neuropsychiatric systemic lupus erythematosus. Systemic Lupus Erythematosus. 4th Ed. 2004;757–83.
28. Ruiz-irastorza G, Olivares N, Ruiz-arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther. 2009;11:1–8. https://doi.org/10.1186/ar2764
29. Yang SC, Lai YY, Huang MC, Tsai CS, Wang JL. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort. Lupus. 2018;1819–27. https://doi.org/10.1177/0961203318792352
30. Kang D, Mok CC. Management of Psychosis in Neuropsychiatric Lupus. J Clin Rheumatol Immunol. 2019;19:9–17. https://doi.org/10.1142/S2661341719300015
31. Fanouriakis A, Bertsias G. Changing paradigms in the treatment of systemic lupus erythematosus. Lupus Sci Med. 2019;6:1–10. https://doi.org/10.1136/lupus-2018-000310
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Theo Audi Yanto, Nathania Raphaeli Mulia, Abraham Fatah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
MEDICINUS is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Copyright © Fakultas Kedokteran | Universitas Pelita Harapan | Lippo Karawaci, Tangerang, Indonesia, 15811 . All rights reserved. p-ISSN 1978-3094 | e-ISSN 2622-6995